Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Huanhua Pharmaceutical is a China-based pharmaceutical company that specializes in the research, development, and production of chemical drugs and high-quality pharmaceutical intermediates. Established in 2014 and headquartered in the Fengxian District of Shanghai, the company focuses on the synthesis of complex small molecules and active pharmaceutical ingredients (APIs). Its operations span the entire drug development process, including laboratory R&D, pilot-scale testing, and commercial manufacturing. The company serves as a key player in the pharmaceutical supply chain, providing essential chemical entities for both innovative drug discovery and generic drug production. Shanghai Huanhua Pharmaceutical leverages its expertise in organic synthesis and process chemistry to support the global life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 上海桓华制药.